Status:
UNKNOWN
A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to Enhance Hepatitis C Treatment Uptake Following Dried Blood Spot Hepatitis C RNA Testing Among People With Recent Injecting Drug Use Attending Needle and Syringe Programs
Lead Sponsor:
Kirby Institute
Conditions:
Hepatitis C, Chronic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A pilot two-arm, individual-level, randomised controlled trial to assess the effect of an intervention integrating contingency management (financial incentives) to enhance hepatitis C treatment uptake...
Eligibility Criteria
Inclusion
- Participants have voluntarily signed the informed consent form
- 18 years of age or older
- Recent injecting drug use (previous six months)
Exclusion
- 1\) Inability or unwillingness to provide informed consent
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04428346
Start Date
October 1 2022
End Date
December 1 2023
Last Update
April 14 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.